CMMB Chemomab Therapeutics Ltd.
Healthcare$2.03+0.49%ClosedMarket Cap: $12.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.51
P/S
0.00
EV/EBITDA
-0.82
DCF Value
$1.56
FCF Yield
-90.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-67.8%
ROA
-63.1%
ROIC
-74.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.0M | $-1.9M | $— | — |
| FY null | $0.00 | NaN% | $-9.6M | $-9.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.8M | $-1.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.3M | $-2.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.5M | $-3.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.2M | $-3.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-14.7M | $-13.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.7M | $-3.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-3.8M | $-3.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.0M | $-3.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-3.8M | $-3.5M | $-1.06 | — |